Castle Creek Pharmaceuticals
Bedminster, US · Founded 2015 · Delaware LLC · 1 known investors
Biotech
Founders & leadership
GL
Greg LicholaiPresident
MD
Michael DerbyChief Executive Officer and Secretary
JA
Jeffrey AroninNamed on SEC filing
Board
AG
Antonio GraciasinBoard directorFounder, Chief Executive Officer & Chief Investment Officer at Valor Equity Partners
PM
Patrick MorrisBoard director
TC
Timothy CunniffBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$48M disclosed across 1 round · 2016
▶$48MraisedOct 2016 · 6 investors · PharmaceuticalsRule 506(b)
▶$48MraisedOct 2016 · 6 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Antonio GraciasDirector
- Jeffrey AroninDirector
- Patrick MorrisDirector
- Greg LicholaiExecutive Officer
- Michael DerbyExecutive Officer, Director
- Timothy CunniffDirector
- Offering amount
- $48M
- Amount sold
- $48M
- Sales commissions
- $1.9M
- Placement agents
- Octagon Capital Group, LLC
- First sale
- Sep 2016
- Incorporated
- Limited Liability Company, Delaware, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Castle Creek Pharmaceuticals's investors?
- Castle Creek Pharmaceuticals's investors include Valor Equity Partners.
- How much funding has Castle Creek Pharmaceuticals raised?
- Castle Creek Pharmaceuticals has disclosed $48M raised across 1 round.
- Where is Castle Creek Pharmaceuticals headquartered?
- Castle Creek Pharmaceuticals is headquartered in Bedminster, US.